市場調査レポート
商品コード
1558421

解剖病理学の世界市場規模・予測、世界・地域別シェア、動向、成長機会分析:製品・サービス別、用途別、エンドユーザー別、地域別

Anatomic Pathology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 178 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.74円
解剖病理学の世界市場規模・予測、世界・地域別シェア、動向、成長機会分析:製品・サービス別、用途別、エンドユーザー別、地域別
出版日: 2024年08月28日
発行: The Insight Partners
ページ情報: 英文 178 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の新しい調査レポート「解剖病理学市場の2031年までの予測- 世界の分析- 製品・サービス、用途、エンドユーザー、地域別」によると、同市場の規模は2023年の302億2,000万米ドルから成長し、2031年には532億7,000万米ドルに達すると予測されており、2023年~2031年にCAGR7.3%を記録する見込みです。がんと腎臓病の有病率の増加と戦略的イニシアチブの増加が解剖病理学市場の成長に寄与しています。しかし、熟練した専門家の不足や政府の厳しい規制が市場成長の妨げとなっています。さらに、人工知能と機械学習の統合は、今後数年間で新しい解剖病理学市場の動向をもたらすと予想されます。

解剖病理学とは、臓器や組織を研究して特定の疾患の原因と影響を明らかにする学問です。解剖病理学は、全体的(肉眼的)にも顕微鏡的にも、身体の器官の構造に対する病気の影響を研究する医学の一分野です。解剖病理学の主な役割は、病気の診断や治療管理に役立つ異常を特定することです。解剖病理学は、様々な種類の腫瘍やがんの同定と管理に役立つことが多くありますが、例えば腎臓や肝臓の疾患、自己免疫疾患、感染症など、他の疾患の評価にも有用です。

2023年の世界の解剖病理学市場では、北米が大きなシェアを占めています。北米の解剖病理学市場は、米国、カナダ、メキシコに区分されます。

米国では、がんが社会に大きな影響を与えています。米国でよく見られるがんの種類は、乳がん、肺がん、気管支がん、前立腺がん、結腸・直腸がん、肝臓がんなどです。 がんサバイバーの数は2030年までに2,220万人に達すると予測されています。このようながん患者の増加により、生検、細針吸引(FNA)、遺伝子検査、その他の新しい技術などの病理診断検査の需要が増加すると予想されます。さらに、米国では近年、革新的で改良された医療技術がかつてないほど伸びています。この成長は、ヘルスケア産業における先進医療機器の開発につながりました。米国の解剖病理学市場で事業を展開する企業は、病理学的処置のための革新的で利便性の高い機器や消耗品の開発に継続的に注力しています。2023年11月、DNAシーケンシングとアレイベース技術の世界的リーダーである米国イルミナは、組織ベースの検査を補完し、血液から循環腫瘍DNAの包括的な非侵襲的ゲノムプロファイリングを可能にする分散型リキッドバイオプシーアッセイの新バージョンであるTruSight Oncology 500 ctDNA v2(プレート番号1 ctDNA v2)を発表しました。2020年、F.ホフマン・ラ・ロシュは米国食品医薬品局(FDA)より、臨床医による子宮頸がん予防を支援するCINtec PLUS細胞診検査の使用拡大承認を取得しました。このように、がんの有病率の高さ、大手企業の存在感の大きさ、病院や臨床検査室に質の高いインフラが整っていることなどが、米国の解剖病理学市場の成長を後押ししています。

政府や民間の農業団体は、作物の特性を改善するために作物ゲノミクスの進歩に非常に注目しています。National Institute of Food and AgricultureのAgricultural Genome to Phenome Initiative(AG2PI)は、作物と動物の遺伝学の両方を研究する研究者のコミュニティを発展させるための共同作業に重点を置いており、これは米国の農業部門にとって重要なゲノムとフェノームに関する知識を拡大する基盤を築くことになります。このイニシアティブは、天候や環境、生産システムの変化が、作物や動物の遺伝的多様性にどのような影響を与えるかを理解するためのアプローチを開発することにつながると思われます。このように、収量や品質の向上を目的とした作物の遺伝子構成に関連する研究を促進する取り組みが増加していることは、将来的に米国の解剖病理学市場に有利に働く可能性が高いです。

個別化医療への注目の高まりが今後の市場機会をもたらす

個別化医療は、主に個人の遺伝子プロファイルを考慮して設計され、病気の予防、診断、治療に関する意思決定の指針となります。医薬品メーカーにとっては、意図したとおりに薬が効かない患者グループや、従来のヘルスケアでは期待通りの効果が得られない患者グループをターゲットにした薬剤を開発する機会を提供することになります。薬物反応のばらつきのかなりの部分が、年齢、栄養状態、環境暴露、健康状態など、遺伝的に制御された要因に依存していることを示す多くの証拠があります。ゲノミクスは個別化医療の出現において重要な役割を果たしています。患者の遺伝子プロファイルを知ることは、医師が適切な薬剤を選択するのに役立つからです。個別化医療は、各患者がより早い診断、リスク評価、最適な治療を受けられるようにすることで、ヘルスケアの向上に役立ちます。

病理医は、分子検査やゲノム検査の開発と実践において重要な役割を果たしています。個別化抗がん剤は、乳がんや心血管疾患などの治療に用いられています。個別化抗がん剤は、より特異的に作用するように設計されているため、他の治療法よりも副作用が少なく、重篤な副作用も少ないです。さらに、研究や臨床研究が進むにつれて、個別化抗がん剤は患者ケアの質を向上させる可能性がさらに高まっています。このように、個別化医療への注目の高まりは、解剖病理学市場の成長を後押しすると予想されます。

解剖病理学市場の競合情勢と主な発展

F.Hoffmann-La Roche Ltd、Beckman Coulter Inc、Hologic Inc、Agilent Technologies Inc、BioGenex Laboratories Inc、Diapath S.p.A.、Bio SB、Merck KGaA、BD、PHC Holdings Corporationなどが、解剖病理学市場で事業を展開する主要企業です。

米国食品医薬品局、疾病管理予防センター(CDC)、経済協力開発機構などは、解剖病理学市場レポート作成時に参照した一次情報および二次情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 解剖病理学市場の情勢

  • PEST分析

第5章 解剖病理学市場:主要市場力学

  • 解剖病理学市場- 主な市場力学
  • 市場促進要因
    • がんと腎臓病の増加
    • 戦略的イニシアチブの増加
  • 市場抑制要因
    • 熟練した専門家の不足
    • 厳しい政府規制
  • 市場機会
    • 個別化医療への注目の高まり
  • 今後の動向
    • 人工知能と機械学習の統合
  • 促進要因と抑制要因の影響

第6章 解剖病理学市場:世界市場分析

  • 解剖病理学市場の収益(2021年~2031年)
  • 解剖病理学市場の予測分析

第7章 解剖病理学市場の分析-製品・サービス別

  • サービス
  • 器具
  • 消耗品

第8章 解剖病理学市場の分析-用途別

  • 疾病診断
  • 創薬・医薬品開発
  • その他

第9章 解剖病理学市場の分析-エンドユーザー別

  • 病院
  • 研究機関
  • 診断研究所
  • その他

第10章 解剖病理学市場- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 業界情勢

  • 解剖病理学市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Beckman Coulter Inc
  • Hologic Inc
  • Agilent Technologies Inc
  • BioGenex Laboratories Inc
  • Diapath S.p.A.
  • Bio SB
  • Merck KGaA
  • PHC Holdings Corporation

第13章 付録

図表

List Of Tables

  • Table 1. Anatomic Pathology Market Segmentation
  • Table 2. Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
  • Table 4. Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 6. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 7. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 8. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 9. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 11. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 12. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 13. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 14. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 15. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 16. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 17. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 18. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 19. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 20. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 21. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 22. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 23. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 24. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 26. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 27. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 28. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 29. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 30. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 31. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 32. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 33. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 34. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 35. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 36. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 37. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 38. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 39. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 40. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 41. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 42. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 43. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 44. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 45. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 46. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 47. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 48. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 49. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 51. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 52. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 53. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 54. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 55. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 56. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 57. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 58. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 59. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 60. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 61. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 62. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 63. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 64. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 65. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 66. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 67. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 68. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 69. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 70. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 71. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 72. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 73. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 74. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 75. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 76. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 77. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 78. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 79. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 80. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 81. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 82. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 83. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 84. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 85. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 86. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 87. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 88. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 89. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 90. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 91. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 92. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 93. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 94. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 95. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 96. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 97. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 98. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 99. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 100. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 101. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 102. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 103. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 104. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 105. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 106. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 107. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 108. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 109. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 110. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 111. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 112. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 113. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 114. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 115. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 116. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 117. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 118. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 119. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 120. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 121. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 122. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 123. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 124. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 125. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 126. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 127. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 128. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 129. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 130. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 131. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 132. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 133. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 134. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 135. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 136. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
  • Table 137. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 138. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 139. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 140. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 141. Recent Organic Growth Strategies in Anatomic Pathology Market
  • Table 142. Recent Inorganic Growth Strategies in the Anatomic Pathology Market
  • Table 143. Glossary of Terms, Anatomic Pathology Market

List Of Figures

  • Figure 1. Anatomic Pathology Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Anatomic Pathology Market Revenue (US$ Million), 2021-2031
  • Figure 5. Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
  • Figure 6. Services: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Instruments: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Consumables: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Disease Diagnosis: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Drug Discovery and Development: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
  • Figure 14. Hospitals: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Research Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Diagnostic Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Anatomic Pathology Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 19. North America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. North America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. United States: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Canada: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Europe: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Germany: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. France: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Italy: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Spain: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Asia Pacific: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 34. China: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Japan: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. India: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Australia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Middle East and Africa: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. South and Central America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 48. Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Growth Strategies in Anatomic Pathology Market
目次
Product Code: TIPRE00002999

According to our new research study on "Anatomic Pathology Market Forecast to 2031 - Global Analysis - by Products and Services, Application, End User, and Geography," the market is anticipated to grow from US$ 30.22 billion in 2023 and is projected to reach US$ 53.27 billion by 2031; it is expected to register a CAGR of 7.3% during 2023-2031. The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are contributing to the anatomic pathology market growth. However, the shortage of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.

Anatomical pathology is the study of organs and tissues to determine the causes and effects of particular diseases. Anatomic (or anatomical) pathology is the branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically. The primary role of anatomic pathology is to identify abnormalities that can help to diagnose disease and manage treatment. Although one of the frequent uses of anatomic pathology is to help identify and manage various types of tumors or cancers, it is also valuable in evaluating other conditions, including kidney and liver diseases, autoimmune disorders, and infections, for example.

North America accounted for a major share of the global anatomic pathology market in 2023. The North America anatomic pathology market is segmented into the US, Canada, and Mexico.

In the US, cancer has a significant impact on society. A few common cancer types in the country are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, and liver cancer. As per the National Cancer Institute, in 2021, ~17.43 individuals were living with cancer at any site in the US. The number of cancer survivors is projected to reach 22.2 million by 2030. This mounting prevalence of cancer cases is expected to increase the demand for pathologic diagnostic tests such as biopsies, fine-needle aspiration (FNA), genetic testing, and other novel techniques. Moreover, there has been unprecedented growth in innovative and improved medical technologies in the US in recent years. This growth resulted in the development of advanced medical devices in the healthcare industry. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. In 2020, F. Hoffmann-La Roche received the US Food and Drug Administration (FDA) approval for the expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer. Thus, factors such as the high prevalence of cancer, strong presence of some major players, and availability of high-quality infrastructure for hospitals and clinical laboratories bolster the growth of the anatomic pathology market in the US.

Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the anatomic pathology market in the US in the future.

Growing Focus on Personalized Medicines to Provide Market Opportunities in Future

Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.

Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.

Anatomic Pathology Market: Competitive Landscape and Key Developments

F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key companies operating in the anatomic pathology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the anatomic pathology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Anatomic Pathology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Anatomic Pathology Market - Key Market Dynamics

  • 5.1 Anatomic Pathology Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increase in Prevalence of Cancer and Kidney Diseases
    • 5.2.2 Rise in Number of Strategic Initiatives
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
    • 5.3.2 Stringent Government Regulations
  • 5.4 Market Opportunities
    • 5.4.1 Growing Focus on Personalized Medicines
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence and Machine Learning
  • 5.6 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Global Market Analysis

  • 6.1 Anatomic Pathology Market Revenue (US$ Million), 2021-2031
  • 6.2 Anatomic Pathology Market Forecast Analysis

7. Anatomic Pathology Market Analysis - by Product and Services

  • 7.1 Services
    • 7.1.1 Overview
    • 7.1.2 Services: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Instruments: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Consumables
    • 7.3.1 Overview
    • 7.3.2 Consumables: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Anatomic Pathology Market Analysis - by Application

  • 8.1 Disease Diagnosis
    • 8.1.1 Overview
    • 8.1.2 Disease Diagnosis: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Drug Discovery and Development
    • 8.2.1 Overview
    • 8.2.2 Drug Discovery and Development: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Anatomic Pathology Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Research Laboratories
    • 9.2.1 Overview
    • 9.2.2 Research Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Diagnostic Laboratories
    • 9.3.1 Overview
    • 9.3.2 Diagnostic Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Anatomic Pathology Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Anatomic Pathology Market Overview
    • 10.2.2 North America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
    • 10.2.4 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
    • 10.2.5 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
    • 10.2.6 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
    • 10.2.7 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
    • 10.2.8 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
      • 10.2.8.1 United States: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services
        • 10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments
        • 10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application
        • 10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User
      • 10.2.8.2 Canada: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services
        • 10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments
        • 10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application
        • 10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User
      • 10.2.8.3 Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services
        • 10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments
        • 10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application
        • 10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Anatomic Pathology Market Overview
    • 10.3.2 Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
    • 10.3.4 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
    • 10.3.5 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
    • 10.3.6 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
    • 10.3.7 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
    • 10.3.8 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
      • 10.3.8.1 United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User
      • 10.3.8.2 Germany: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User
      • 10.3.8.3 France: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User
      • 10.3.8.4 Italy: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User
      • 10.3.8.5 Spain: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User
      • 10.3.8.6 Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services
        • 10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments
        • 10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application
        • 10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Anatomic Pathology Market Overview
    • 10.4.2 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
    • 10.4.4 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
    • 10.4.5 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
    • 10.4.6 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
    • 10.4.7 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
    • 10.4.8 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
      • 10.4.8.1 China: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User
      • 10.4.8.2 Japan: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User
      • 10.4.8.3 India: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User
      • 10.4.8.4 Australia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User
      • 10.4.8.5 South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User
      • 10.4.8.6 Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services
        • 10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments
        • 10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application
        • 10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Anatomic Pathology Market Overview
    • 10.5.2 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
    • 10.5.4 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
    • 10.5.5 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
    • 10.5.6 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
    • 10.5.7 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
    • 10.5.8 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
      • 10.5.8.1 South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services
        • 10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments
        • 10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application
        • 10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User
      • 10.5.8.2 Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services
        • 10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments
        • 10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application
        • 10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User
      • 10.5.8.3 United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services
        • 10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments
        • 10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application
        • 10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User
      • 10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services
        • 10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments
        • 10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application
        • 10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Anatomic Pathology Market Overview
    • 10.6.2 South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
    • 10.6.4 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
    • 10.6.5 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
    • 10.6.6 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
    • 10.6.7 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
    • 10.6.8 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
      • 10.6.8.1 Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services
        • 10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments
        • 10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application
        • 10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User
      • 10.6.8.2 Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services
        • 10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments
        • 10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application
        • 10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User
      • 10.6.8.3 Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services
        • 10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services
        • 10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments
        • 10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application
        • 10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Anatomic Pathology Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 F. Hoffmann-La Roche Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Beckman Coulter Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Hologic Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Agilent Technologies Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 BioGenex Laboratories Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Diapath S.p.A.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Bio SB
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Merck KGaA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 PHC Holdings Corporation
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms